Valiant Organics Limited (VALIANTORG) Fair Value & Analysis
Basic Materials · IN · Market cap ₹7.8B
Fair value as of: Jul 3, 2026
From 26 valuation models · updated today
Share price −7.4% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹197.64 – ₹428.50 · fair‑value band ₹190.54 – ₹251.92 · the ₹278.30 price screens above the ₹210.53 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Valiant Organics Limited (VALIANTORG) currently trades at ₹278.30, while our model-based Fair Value estimate is ₹210.53 — implying the stock looks roughly 24.4% overvalued today. We read business quality at 53/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Valiant Organics Limited generated revenue of ₹7.4B at a net margin of 4.5%. Revenue grew 6.9% year over year. It earns a return on equity of 4.5%. Net debt stands at ₹2.5B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India and internationally. The company offers para chloro phenol; ortho chloro phenol; 2,4 di chloro phenol; 2,4,6 tri chloro phenol; n-isopropyl para chloro aniline; meta chloro aniline; para flouro aniline; 4-flouro-N-isopropylaniline; 2,4-dichlorophenoxyacetic acid; para nitro aniline; ortho chloro para nitro aniline; ortho anisidine; para anisidine; ortho toluidine 5 sulfonic acid; 6 acetyl oapsa; ortho nitro aniline para sulphonic acid; ortho amino phenol; 4B and 2B acid; 2,6 di chloro phenol; and para"amino phenol. It also provides IPPCA, OA/PA acetanilide, OT5SA, ortho nitro anisole, and para nitro anisole. The company's products are primarily used as intermediates in agro chemicals, dyes, pigments, pharmaceuticals, cosmetics, specialty chemicals, polymers, and veterinary drugs. It exports its products to Asia, Europe, and the United States. Valiant Organics Limited …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Valiant Organics Limited reported revenue of ₹7.4B in FY2026 versus ₹11.5B in FY2022, a compound −10.5%/yr. Reported net income was ₹332M in FY2026, compounding −26.4%/yr from FY2022.
Is VALIANTORG fairly valued? → Check now
Similar stocks
6 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | €454.60 | €197.39 | -57% |
| Shin-Etsu Chemical Co SHECY | $22.62 | $12.94 | -43% |
| BASF SE BAS | €49.17 | €23.76 | -52% |
| Ningxia Baofeng Energy Group 600989 | ¥23.43 | ¥34.39 | +47% |
| Dow Inc D1OW34 | R$41.12 | R$16.66 | -59% |
| Ganfeng Lithium Group 002460 | ¥67.60 | ¥22.08 | -67% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Valiant Organics Limited (VALIANTORG) undervalued?
What is the fair value of VALIANTORG?
What is the quality score of VALIANTORG?
What is the revenue of Valiant Organics Limited (VALIANTORG)?
What is the net profit margin of VALIANTORG?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.